Canakinumab Subcutaneous and Difil-G Forte
Determining the interaction of Canakinumab Subcutaneous and Difil-G Forte and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dyphylline / guaifenesin
Brand name: Difil-G Forte, Jay-Phyl, Lufyllin-GG, Dyphylline GG, Dyphyl GG, Difil G, Difil G Forte, Dyline GG, Dilex-G, Panfil G, Dy-G, Dilor-G, Dyflex-G, LGG, Dyfilin GG, D-G, Dyphyllin-GG, COPD, Dilex-G 400, Dilex-G 200, Dyphylline GG ES
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Diflorasone
- Canakinumab Subcutaneous-Diflorasone Cream
- Canakinumab Subcutaneous-Diflorasone Diacetate
- Canakinumab Subcutaneous-Diflorasone topical
- Canakinumab Subcutaneous-Diflorasone Topical application
- Canakinumab Subcutaneous-Diflucan
- Difil-G Forte-Canasa
- Difil-G Forte-Canasa Pac rectal
- Difil-G Forte-Canasa rectal
- Difil-G Forte-Cancidas
- Difil-G Forte-Candesartan
- Difil-G Forte-Candesartan and Hydrochlorothiazide